SightfileU.S. market data from official filings

P3 HEALTH PARTNERS INC (PIII)

Name: P3 HEALTH PARTNERS INC (PIII) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001832511 · EDGAR filings · Updated 2026-07-06

P3 HEALTH PARTNERS INC (PIII) has 16 institutional managers reporting positions valued at $666.5K per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional managers

Reported 13F value

$666.5K

Insider activity

14 trans.

$0 net flat

Data flags

3 active

from SEC filings

Latest updates

2026-07-06 — Current report (8-K) filed
2026-06-12 — Insider transaction reported (Form 4)
2026-06-10 — Current report (8-K) filed
2026-05-26 — Current report (8-K) filed
2026-05-18 — Insider transaction reported (Form 4)
2026-05-15 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, P3 HEALTH PARTNERS INC has 16 institutional holders.

Insider activity

Insiders reported 14 transactions (0 buys, 0 sells) across 7 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-05-26 (recurring since 2021-12-09) — source filing. The authoritative details are those stated in the filing itself.

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-14 (recurring since 2021-04-06) — source filing. The authoritative details are those stated in the filing itself.

Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2022-04-25 (recurring since 2021-05-24) — source filing. The authoritative details are those stated in the filing itself.

Related companies

GENENTA SCIENCE S P A (GNTA) · BONE BIOLOGICS CORP (BBLG) · Exicure Inc (XCUR) · Kiora Pharmaceuticals Inc (KPRX) · GT BIOPHARMA INC (GTBP) · PHARMACYTE BIOTECH INC (PMCB)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-06.